Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Goodwill & Intangibles (2016 - 2026)

Lexaria Bioscience's Goodwill & Intangibles history spans 12 years, with the latest figure at $20193.0 for Q1 2026.

  • On a quarterly basis, Goodwill & Intangibles fell 96.01% to $20193.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $20193.0, a 96.01% decrease, with the full-year FY2025 number at $307818.0, down 40.42% from a year prior.
  • Goodwill & Intangibles hit $20193.0 in Q1 2026 for Lexaria Bioscience, up from $5099.0 in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for LEXX hit a ceiling of $549122.0 in Q2 2023 and a floor of $5099.0 in Q4 2025.
  • Historically, Goodwill & Intangibles has averaged $358795.1 across 5 years, with a median of $488462.0 in 2022.
  • Biggest five-year swings in Goodwill & Intangibles: skyrocketed 574.54% in 2023 and later tumbled 98.99% in 2025.
  • Tracing LEXX's Goodwill & Intangibles over 5 years: stood at $500549.0 in 2022, then decreased by 1.23% to $494377.0 in 2023, then increased by 2.22% to $505373.0 in 2024, then tumbled by 98.99% to $5099.0 in 2025, then surged by 296.02% to $20193.0 in 2026.
  • Business Quant data shows Goodwill & Intangibles for LEXX at $20193.0 in Q1 2026, $5099.0 in Q4 2025, and $307818.0 in Q3 2025.